Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) Pantoprazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel purification method ensures high purity and stability. Reduces impurities for reliable pharmaceutical intermediates supply chain and significant cost efficiency gains.
Patent CN102603716B details a base-free asymmetric oxidation for (S)-pantoprazole. This report analyzes the cost reduction in API manufacturing and supply chain reliability for this proton pump inhibitor intermediate.
Patent CN102603716A details a novel titanium-catalyzed asymmetric oxidation for (S)-pantoprazole. Achieve 100% ee value with streamlined processing for reliable pharmaceutical intermediate supply.